A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: The BELIEVE study

D. Thaçi*, J. P. Ortonne, S. Chimenti, P. D. Ghislain, P. Arenberger, K. Kragballe, J. H. Saurat, A. Khemis, P. Sprøgel, H. U. Esslinger, K. Unnebrink, H. Kupper

*Corresponding author for this work
79 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: The BELIEVE study'. Together they form a unique fingerprint.

Medicine & Life Sciences